OFS
ABBV icon

OneAscent Financial Services’s AbbVie ABBV Stock Holding History

OneAscent Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75M Buy
12,633
+3,869
+44% +$858K 0.15% 98
2025
Q4 		$2M Buy
8,764
+484
+6% +$110K 0.18% 80
2025
Q3 		$1.92M Sell
8,280
-2,642
-24% -$538K 0.24% 82
2025
Q2 		$2.04M Sell
10,922
-282
-3% -$52.4K 0.15% 100
2025
Q1 		$2.34M Buy
11,204
+932
+9% +$181K 0.15% 97
2024
Q4 		$1.82M Buy
10,272
+1,490
+17% +$274K 0.16% 92
2024
Q3 		$1.73M Sell
8,782
-548
-6% -$102K 1.25% 13
2024
Q2 		$1.6M Sell
9,330
-196
-2% -$32.5K 0.22% 58
2024
Q1 		$1.74M Sell
9,526
-975
-9% -$168K 0.19% 74
2023
Q4 		$1.63M Buy
10,501
+4,471
+74% +$652K 0.2% 70
2023
Q3 		$899K Buy
6,030
+1,191
+25% +$175K 0.23% 78
2023
Q2 		$652K Buy
4,839
+929
+24% +$136K 0.29% 40
2023
Q1 		$623K Sell
3,910
-601
-13% -$91.9K 0.25% 41
2022
Q4 		$729K Sell
4,511
-1,216
-21% -$186K 0.31% 41
2022
Q3 		$769K Buy
5,727
+38
+0.7% +$5.45K 0.31% 53
2022
Q2 		$871K Buy
5,689
+2,335
+70% +$357K 0.4% 37
2022
Q1 		$544K Buy
+3,354
New +$487K 0.39% 33
2021
Q4 		– Sell
-2,385
Closed -$257K – 138
2021
Q3 		$257K Buy
+2,385
New +$273K 0.34% 66
2020
Q4 		– Sell
-10,179
Closed -$892K – 129
2020
Q3 		$892K Buy
10,179
+606
+6% +$57.1K 0.47% 28
2020
Q2 		$940K Buy
9,573
+969
+11% +$85.3K 0.63% 19
2020
Q1 		$656K Sell
8,604
-1,631
-16% -$139K 0.49% 18
2019
Q4 		$906K Buy
+10,235
New +$850K 0.5% 16
2019
Q3 		– Sell
-11,022
Closed -$802K – 19
2019
Q2 		$802K Buy
+11,022
New +$866K 0.55% 19

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OneAscent Financial Services's ABBV Position: Q1 2026 in Review

OneAscent Financial Services increased its AbbVie (ABBV) stake by 44% in Q1 2026, buying an estimated $858K and bringing the position to 12,633 shares worth $2.75M. The position accounts for 0.15% of the portfolio, ranked #98.

OneAscent Financial Services first reported a position in ABBV in Q2 2019 and has held it in 23 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • OneAscent Financial Services held 12,633 shares of AbbVie worth $2.75M as of Q1 2026.
  • OneAscent Financial Services bought 3,869 AbbVie shares in Q1 2026, an estimated $858K.
  • AbbVie made up 0.15% of OneAscent Financial Services's portfolio in Q1 2026, its #98 holding.
  • OneAscent Financial Services first reported a position in AbbVie in Q2 2019 and has held it in 23 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on OneAscent Financial Services's 13F filing for Q1 2026, filed 21 Apr 2026.